Vytorin detailed information

Jump to navigation Jump to search
Template:Chembox header| Simvastatin and Ezetimibe


Simvastatin

Ezetimibe

Other names Vytorin

WikiDoc Resources for Vytorin detailed information

Articles

Most recent articles on Vytorin detailed information

Most cited articles on Vytorin detailed information

Review articles on Vytorin detailed information

Articles on Vytorin detailed information in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Vytorin detailed information

Images of Vytorin detailed information

Photos of Vytorin detailed information

Podcasts & MP3s on Vytorin detailed information

Videos on Vytorin detailed information

Evidence Based Medicine

Cochrane Collaboration on Vytorin detailed information

Bandolier on Vytorin detailed information

TRIP on Vytorin detailed information

Clinical Trials

Ongoing Trials on Vytorin detailed information at Clinical Trials.gov

Trial results on Vytorin detailed information

Clinical Trials on Vytorin detailed information at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Vytorin detailed information

NICE Guidance on Vytorin detailed information

NHS PRODIGY Guidance

FDA on Vytorin detailed information

CDC on Vytorin detailed information

Books

Books on Vytorin detailed information

News

Vytorin detailed information in the news

Be alerted to news on Vytorin detailed information

News trends on Vytorin detailed information

Commentary

Blogs on Vytorin detailed information

Definitions

Definitions of Vytorin detailed information

Patient Resources / Community

Patient resources on Vytorin detailed information

Discussion groups on Vytorin detailed information

Patient Handouts on Vytorin detailed information

Directions to Hospitals Treating Vytorin detailed information

Risk calculators and risk factors for Vytorin detailed information

Healthcare Provider Resources

Symptoms of Vytorin detailed information

Causes & Risk Factors for Vytorin detailed information

Diagnostic studies for Vytorin detailed information

Treatment of Vytorin detailed information

Continuing Medical Education (CME)

CME Programs on Vytorin detailed information

International

Vytorin detailed information en Espanol

Vytorin detailed information en Francais

Business

Vytorin detailed information in the Marketplace

Patents on Vytorin detailed information

Experimental / Informatics

List of terms related to Vytorin detailed information

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Ezetimibe/simvastatin (IPA: Template:IPA) is a drug combination used for the treatment of dyslipidemia. It is a combination of ezetimibe (best known as Zetia in the United States) and the statin drug simvastatin (best known as Zocor in the U.S.). The combination preparation is marketed by Merck & Co./Schering-Plough Pharmaceuticals (joint venture) under the trade names Vytorin and Inegy.

Ezetimibe works by reducing the amount of cholesterol that the body absorbs from the food ingested.

Simvastatin is an HMG-CoA reductase inhibitor or statin. It works by blocking an enzyme that is necessary for the body to make cholesterol.

Contraindications

Side effects

Interactions

External links

Template:Statins


Template:WikiDoc Sources